Home About Us Contact Us

Official Journals By StatPerson Publication

Table of Content - Volume 5 Issue 1 - January 2018

 

 

.

Assessment of hypothyroidism among Type II DM patients attending in a rural teaching hospital, Sangareddy

 

Pawan Arun Kulkarni1, Nagababu Pyadala1,2,*, Sarala Devi Tenepalli3,

Rathnagiri Polavarapu4

 

1Assistant Professor, Department of Biochemistry, MNR Medical College and Hospital, Sangareddy, Telangana State, India.

2Research Associate, Department of Clinical Research Laboratory, Genomix Molecular Diagnostics Pvt. Ltd, Kukatpally, Hyderabad, India.

3Professor, Department of Biochemistry, MNR Medical College and Hospital, Sangareddy, Telangana State, India.

4President and CEO, Genomix CARL Pvt. Ltd, Pulivendula, Andhra Pradesh, India.

Email: nagababu00799@gmail.com  

 

Abstract               Background: The present study was undertaken to assess the interdependent relationship between type 2 DM and hypothyroidism among Type 2 diabetic patients attending a teaching hospital. Materials and methods: In the present study, 100 type 2 diabetic subjects and 100 healthy nondiabetic subjects investigated for total triiodothyronine (T3), total thyroxine (T4), thyroid stimulating hormone (TSH), and Fasting blood sugar (FBS). Results: The level of T3 and T4 were significantly lower while the level of TSH and FBS was substantially higher in type 2 diabetics as compared to non-diabetics. Conclusion: Thus, the present study was conducted to find out the relationship between type 2 DM and hypothyroidism in patients with type 2 diabetes. Prevalence of Hypothyroidism is high among Type 2 Diabetes mellitus patients especially females. Therefore continuous screening for thyroid hormones is suggested in type 2 DM patients to reduce the vascular complications and management of diabetes and also reduce the risk of thyroid hormone dysfunction.

Keywords: Diabetes mellitus, Hypothyroidism, Triidothyronine (T3), Tetraidothyronine (T4), Thyroid stimulating hormone (TSH).

 

 

INTRODUCTION

Diabetes mellitus (DM) is most common endocrine disorder and characterized by high blood sugar levels over a prolonged period. DM occurs due to the deficiency of insulin secretion of insulin resistance or both. The impact of the DM depends upon the quality of life, and on mortality and morbidity through the complication that is affecting the large and small vessels resulting in neuropathy, nephropathy, and retinopathy. In India, the incidence is increasing day by day due to a sedentary lifestyle and high degree of genetic predisposition. By 2020 in India the frequency may reach to 70 million and WHO declared India as the diabetes capital of the world. If a person affected by DM, there is a chance to get another endocrine gland dysfunction that is thyroid gland.1,2,3,4 Hypothyroidism is another common endocrine disorder resulting from a deficiency of thyroid hormone. Thyroid dysfunctions increasingly found in the T2DM patients and prevalence is around 13.4%5 The presence of thyroid dysfunction may affect DM control, and plasma lipid metabolism increases the risk of cardiovascular disease (CVD) and atherosclerosis. Among DM, Type 2 DM or Non-insulin dependent diabetes mellitus (NIDDM) is most common in India, and the incidence is increasing day by day. Patients with type 2 DM have the significantly higher prevalence of thyroid disorder especially hypothyroidism when compared with the healthy population.6,7,8 Therefore the present study aimed to assess the association of hypothyroidism in type 2 DM patients attending a rural teaching hospital.

 

METHODS AND MATERIALS

The present study was carried out at MNR Medical College and Hospital situated in Sangareddy, Telangana state. A total of 200 study subjects of both gender groups selected from the medicine ward of MNR Hospital during the period from May 2017 to November 2017. This study approved by institutional ethical committee and investigations were carried out in the biochemistry laboratory, MNR Medical College and Hospital, Sangareddy.

Inclusion Criteria: All patients with Type 2 diabetes aged more than 30 years. All people with diabetes irrespective of glucose control. All people with diabetes regardless of treatment (OHA/insulin).

Exclusions criteria: Type 1 DM. Patients with: 1. Gestational diabetes mellitus. 2. Fibrocalculouspancreatitis. 3. Pancreatitis. 4. Steroid-induced Diabetes would exclude. All those who had proven thyroid disorder and on treatment.

Sample collection: Blood samples were collected, after 12 hours fast from the above study subjects. 5ml of blood from the cubital vein received in a plain bottle after explaining the procedure to the study subjects. Serum was separated from the blood samples by a centrifuged machine at 3000 rpm for 10 minutes in the biochemistry department. Following estimations are carried out on the serum samples by standard kit methods, and analyses performed on COBAS e411 autoanalyzer.

  • Triidothyronine (T3)
  • Tetraidothyronine (T4)
  • Thyroid stimulating hormone (TSH)
  • FBS

Blood glucose estimated by using GOD-POD method [Robonik-semi auto-analyser) and [1,2,3], T3, T4 and TSH-estimated by using (CLIA -method) chemi luminescence immune assay method [1,8,9].

Reference range: The normal reference ranges according to the kits are: TSH (0.7-6.4 μIU/ml), T3 (0.52-1.85 ng/ml), T4 (4.0-11.0 μg/dl. Normal values for FBS 70-110mg/dl.

Statistical analysis: The collected data were analyzed by SPSS software version 16.0. All results presented as the mean ± standard deviation (SD). A p-value of < 0.0001 was considered significant.

RESULTS

In the present study, total 200 subjects were included and divided into two groups, 100 controls (non-diabetic) and 100 cases (diabetic) with the age range of 30 – 60 years. Out of 100 non-diabetic controls 27 were females and 73 males and in 100 diabetic cases, 72 were females and 28 males as shown in the Table 1, Figure 1 and Figure 2.


 

Table  1: Gender and Age wise distribution of controls and cases

Age

Cases (n=100)

Controls (n=100)

Male

Female

Male

Female

30-40

10

23

10

23

41-50

13

32

12

33

51-60

04

18

04

18

Total

27

73

26

74

Mean ± SD

44.59 ± 5.82

44.61 ± 5.89

 

Table 2: Comparison of FBS and thyroid profile among Cases and controls

Parameters

Cases

(Type 2 DM)

Mean ± SD

Controls

(Non-Diabetic)

Mean ± SD

P-Value

Student ‘t’ test

Significance

FBS (mg/dl)

138.93 ± 12.45

89.97 ± 9.77

<0.0001

31.00

s**

T3 (ng/ml)

45.70 ± 12.74

136.43 ± 36.38

<0.0001

23.53

s**

T4 (μg/dl)

1.881 ± 1.23

7.211 ± 2.36

<0.0001

19.95

s**

TSH (μIU/ml)

6.103 ± 0.092

2.384 ± 0.883

<0.0001

29.12

s**

S** = extremely statistically significant

 

1

      Figure 1: Gender wise distribution of cases                Figure 2: Gender wise distribution of controls

 


DISCUSSION

In the present study, we assessed the association between hypothyroidism and typed 2 DM. in the present study the mean ± SD of the FBS and TSH were significantly increased in type 2 DM patients when compared with controls (non-diabetics) [ Table 2]. In the present study, high incidence of cases seen in 41-50. Similar studies reported by Kiran Kumar Akka et al., 20171, Desai JP, et al., 201510, Luboshitzky, et al., 200211. Females subjects’ incidence is more than the males of total cases. Similar findings were reported by Bhandopadhyay SK et al., 2006.12 According to Aminorroaya A et al., 2009; the percentage of thyroid dysfunction among women 13% and men only 5 %13 In the present study, the mean ± SD levels of fasting blood sugar significantly higher in type2 DM patients than that of healthy non-diabetic type subjects. Similar findings were reported by Swamy RM et al., 2012 [14], Reeta T, et al.15, Priti S, et al.16, and Samatha P, et al.17. The TSH level was significantly higher in diabetic subjects as compared to healthy control subjects. Similar findings were reported by Swamy RM et al., 201214 and Singh G, et al.18 The T3 and T4 levels were significantly decreased in diabetic subjects as compared to healthy control subjects. Similar findings were reported by Swamy RM et al., 201214, Kiran Kumar Akka et al., 20171 and Haque S S, et al.19 Thyroid hormones may influence glucose control through a variety of actions on intermediary metabolism. In patients with diabetes, hypothyroidism may affect metabolic control through effects on glucose metabolism, which include reductions in hepatic glucose output, gluconeogenesis, and peripheral glucose utilization. The result of these processes is a predisposition to hypoglycaemia.20 Co-existent diabetes may also affect the efficacy of thyroid hormone treatment in patients with hypothyroidism.21

 

CONCLUSION

                Thus, the present study was conducted to find out the relationship between type 2 DM and hypothyroidism in patients with type 2 diabetes. Prevalence of Hypothyroidism is high among Type 2 Diabetes mellitus patients especially females. Therefore continuous screening for thyroid hormones is suggested in type 2 DM patients to reduce the vascular complications and management of diabetes and also reduce the risk of thyroid hormone dysfunction.

 

ACKNOWLEDGEMENT

We are thankful to Genomix Molecular Diagnostics Pvt. Ltd, Hyderabad, for their invaluable help and support.

 

REFERENCES

  1. Kiran Kumar Akka, Pampareddy B. Kollur, S.M. Awanti, Nagababu Pyadala. Evaluation of thyroid profile among type 2 diabetic patients attending to Basaveswara Teaching and General Hospital, Kalaburagi, Karnataka. IAIM, 2017; 4(6): 181- 186.
  2. Sarala Devi Tenepalli, Nagababu Pyadala. Assessment of Oxidative Stress among Type 2 Diabetes Mellitus Patients Attending in A Rural Teaching Hospital, Sangareddy. IOSR Journal of Biotechnology and Biochemistry (IOSR-JBB) Volume 2, Issue 5 (Jul. – Aug. 2016), PP 24-27.
  3. Nagababu Pyadala, Ravindra Reddy Bobbiti, Ragalikhith Kesamneni, Rajaneesh Borugadda, Ravi Kumar, B. N, R.Vijayaraghavan, Rathnagiri Polavarapu. Association of Glycosylated hemoglobin and Lipid profile levels among Type 2 diabetic patients in Sangareddy. Research Journal of Pharmaceutical, biological and chemical Sciences. 7(5) Page No. 2849.
  4. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T (4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab., 2002; 87: 489–99.
  5. Perros P, mccrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabetic Medicine 1995; 12 (7) 622– 627.
  6. Wu P : Thyroid disease and diabetes. Clin Diabetes. 2000;18(1):38-41.
  7. Celani MF, Bonati ME, Stucci N, et al. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus. Diabetes Res. 1994; 27(1):15-25.
  8. Bandi A, Pyadala N, Srivani N, Borugadda R, Maity SN, Ravi Kumar BN, Polavarapu R. A comparative assessment of thyroid hormones and lipid profile among hypothyroid patients: A hospital based case control study. IAIM, 2016; 3(9): 108- 114.
  9. Thyroid function chapter no: 40 in TIETZ fundementals of clinical chemistry, 5th edition, Saunders publication, 2001, p. 839-856.
  10. Desai JP, Vachhani UN, Modi G, Chauhan K. A study of correlation of serum lipid profile in patients with hypothyroidism. Int J Med Sci Public Health, 2015; 4: 1108- 1112.
  11. Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroid-ism. Thyroid, 2002; 12: 421–5.
  12. Bhandopadhyay SK, Basu AK, Pal SK, Roy P, Chakrabarti S, Pathak HS, et al. Study of dyslipidemia in subclinical hypothyroidism. J Indian Med Assoc., 2006; 104: 622–6.
  13. Aminorroaya A, Janghorbani M, Amini A, et al. the prevalence of thyroid dysfunction in an iodine sufficient area in Iran. Arch Iranian Med., 2009; 12: 262-270.
  14. Swamy RM, Naveen Kumar, Srinivasa K, Manjunath GN, Prasad Byrav DS, Venkatesh G. Evaluation of hypothyroidism as a complication in Type II Diabetes Mellitus. Biomedical Research 2012; 23 (2): 170-172
  15. Reeta T, Bindu SM, Smita M. Evaluation of Thyroid Dysfunction in Type II Diabetes Mellitus: A Case Control Study. International Journal of Current Medical And Applied Sciences, 2013; 1(1): 16-20.
  16. Priti S, Salman K, Rabindra Kumar M. Evolution of thyroid dysfunction among type-2 diabetic mid and far western Nepalese population. Journal of Coastal Life Medicine, 2014; 2(11): 903-906.
  17. Samatha P, Venkateswarlu M, Siva Prabodh V. Lipid Profile Levels in Type 2 Diabetes Mellitus from the Tribal Population of Adilabad in Andhra Pradesh, India. Journal of Clinical and Diagnostic Research, 2012; 6(4): 590-592.
  18. Singh G, Gupta V, Sharma AK, Gupta N. Evaluation of thyroid Dysfunction among type-2 diabetic population. Advances in Bioresearch, 2011; 2(2): 3-9.
  19. S.S. Haque, R. Kumari, M.A. Muzaffar, B. Kumari, A. Sharan, U. Kumar, S. Kumar. Evaluation of thyroid profile status in case of type-2 diabetes mellitus in North Indian population. Scientific Journal of Microbiology, 2014; 3(5): 62-65.
  20. Somwaru LL, Arnold AM, Joshi N, et al. High frequency of and factors associated with thyroid hormone overreplacement and underreplacement in men and women aged 65 and over. J Clin Endocrinol Metab 2009;94:1342–5.